PRISM MarketView

Quoin Achieves New Milestone with Further Expansion of Global Netherton Syndrome Clinical Trials

New York, October 22, 2024 - PRISM MarketView - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, will extend its ongoing Netherton Syndrome (NS) clinical studies to two additional internati...

22 October 2024

Cowboy Hats are Becoming Acceptable Golf Attire. TopGolf Breaks Ground on 14th Texas Venue

New York, October 21, 2024 - PRISM MarketView - The “ultimate instigator of play” with over 100+ venues around the globe, TopGolf a brand under TopGolf-Callaway Brands Corp. (MODG) has announced it has broken ground on its 14th Texas location in New Braunfels Town Center...

21 October 2024

Trevi Therapeutics Completes Enrollment for Phase 2a Chronic Cough Trial; Topline Results Expected Q1 2025

New York, October 21, 2024 - PRISM MarketView - Trevi Therapeutics (Nasdaq: TRVI) has completed enrollment for its Phase 2a trial evaluating Haduvio™ (oral nalbuphine ER) for the treatment of refractory chronic cough (RCC). The trial, conducted across multiple sites in t...

21 October 2024

A Better Way to Get Baked: Green Thumb Industries incredibles Brand Expands Partnership with World-Famous Magnolia Bakery

New York, October 21, 2024 - PRISM MarketView - Green Thumb Industries (GTBIF) award winning cannabis edibles brand incredibles will be expanding its partnership with New York City’s Magnolia Bakery. This week incredibles’ chocolate will be combining with Magnolia’s icon...

21 October 2024

Taboola Inks Multi-Year Partnership with National World, One of UK’s Largest Regional Publishers

New York, October 21, 2024 - PRISM MarketView - One of the global leaders in powering recommendations for the open web, Taboola (TBLA) has signed an exclusive multi-year partnership with National World, one of the UK’s largest regional publishers with over 15 million mon...

21 October 2024

IceCure Wins U.S. Patent for Next-Generation Cryoablation System; Stock Trading Up 10%

New York, October 21, 2024 - PRISM MarketView - IceCure Medical Ltd. (Nasdaq: ICCM) has secured a Notice of Allowance from the U.S. Patent and Trademark Office for its innovative “Cryogenic System Connector.” This patented technology is a critical component of IceCure’s ...

21 October 2024

Breakthrough Preclinical Results: MIRA Pharmaceuticals’ Ketamir-2 Surpasses Leading Neuropathic Pain Treatments

New York, October 21, 2024 - PRISM MarketView - MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) reports that its novel oral ketamine analog, Ketamir-2, has outperformed FDA-approved neuropathic pain treatments Gabapentin and Pregabalin in a recent preclinical study. Conducted ...

21 October 2024

Immutep Advances First-in-Human Phase I Study of IMP761 to Dose Escalation Phase

New York, October 18, 2024 - PRISM MarketView - Immutep Limited (ASX: IMM; NASDAQ: IMMP), a clinical-stage biotechnology company focused on LAG-3 immunotherapies, announced that its first-in-human Phase I study of IMP761 has progressed to the dose escalation phase. The s...

18 October 2024

Safety and AI: Knightscope Signs Additional Contracts with Healthcare Clients

New York, October 18, 2024 - PRISM MarketView - A leading innovator in robotics and artificial intelligence (AI) technologies with a focus on public safety Knightscope, Inc. (KSCP), announced the signing of two new contracts for its Full Service Maintenance Plan (FSMP) w...

18 October 2024

Poseida Therapeutics Announces New CAR-T Development Candidate Under Roche Collaboration

New York, October 17, 2024 - PRISM MarketView - Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell therapy company, has announced the nomination of a new allogeneic CAR-T therapy candidate as part of its collaboration with Roche. This new dual CAR-T candida...

17 October 2024